Pending testing results, page-186

The pending test results are the talk of the town, but something that falls by the way side is the SIEN-NET test kit being developed.

From the BD1 website -

SIEN-NET:

A biomarker capture platform that uses patented Molecular NETs to capture and purify target molecules from patient samples in a scalable, rapid and cost-effective method for utilisation in high throughput laboratories. The SIEN-NET platform enables the Company to access the rapidly growing liquid biopsy market

After listening to Alan Kohlers interview again this has interested me greatly. Dr Hinch says directly they have intrest that is growing each day for this research kit and it will be available sometime in the 2nd quarter.

Being a research kit obviously limits the market like the H-Tert test. The key difference between the two is that the former is more for research institutions etc. Where as the SIEN-NET test kit, is being showed intrest from big pharma as Dr Hinch clearly states it will be used in ongoing diagnostic tests. And show me a single pharma/cancer big dog that will not want this tech. The current comparable research kit for exosomes takes 6hrs to get a result, SIEN-NET is in 15 minutes.

Now my question is, what value in terms of revenue could this potential make for BD1? I feel this is more exciting than the test results we are all expecting!

Bring on the 2nd Quarter...